Henry Cremisi - 11 Jul 2023 Form 4 Insider Report for DAXOR CORP (DXR)

Role
Director
Signature
/s/ Henry Cremisi
Issuer symbol
DXR
Transactions as of
11 Jul 2023
Net transactions value
$0
Form type
4
Filing time
13 Jul 2023, 16:48:08 UTC
Previous filing
27 Jun 2022
Next filing
17 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DXR Stock Options (right to buy) Award $0 +2,500 $0.000000 2,500 11 Jul 2023 COMMON STOCK 2,500 $9.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on July 11, 2023 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan").
F2 The stock options will vest in three installments on July 11, 2024 (833), July 11, 2025 (883) and July 11, 2026 (834)